We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 9, 2024 to Discuss Your Rights - AMLX PR Newswire NEW YORK, March 26, 2024 NEW YORK, March 26, 2024...
INVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) INVESTORS WITH LOSSES OF MORE THAN $100,000 ENCOURAGED TO SEEK APPOINTMENT AS LEAD PLAINTIFF - April 9, 2024 DEADLINE PR Newswire SAN...
The Gross Law Firm Notifies Shareholders of Amylyx Pharmaceuticals, Inc.(AMLX) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, March 22, 2024 NEW YORK, March 22, 2024...
Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 9, 2024 to Discuss Your Rights - AMLX PR Newswire NEW YORK, March 19, 2024 NEW YORK...
- Dr. Zeiher brings more than 20 years of drug development experience in areas with serious unmet treatment needs at companies including Astellas Pharma, Pfizer, Eli Lilly and Company, and Merck...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 9, 2024 in Amylyx Lawsuit - AMLX PR Newswire NEW YORK, March 14, 2024 NEW YORK, March 14, 2024 /PRNewswire/ --ย The...
Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to §...
Amylyx Pharmaceuticals, Inc. Class Action: The Gross Law Firm Reminds Amylyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX PR Newswire NEW...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -5.61056105611 | 3.03 | 3.03 | 2.67 | 2192328 | 2.79826234 | CS |
4 | -16.94 | -85.5555555556 | 19.8 | 19.9488 | 2.67 | 6506558 | 4.43507972 | CS |
12 | -13.3 | -82.301980198 | 16.16 | 19.9488 | 2.67 | 3012184 | 7.51254659 | CS |
26 | -15.76 | -84.6401718582 | 18.62 | 19.9488 | 2.67 | 2253486 | 10.37979307 | CS |
52 | -27.57 | -90.6013802169 | 30.43 | 31.77 | 2.67 | 1651136 | 14.58561816 | CS |
156 | -18.14 | -86.380952381 | 21 | 41.9297 | 2.67 | 1275963 | 19.49128034 | CS |
260 | -18.14 | -86.380952381 | 21 | 41.9297 | 2.67 | 1275963 | 19.49128034 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions